Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
8.99 USD | +1.12% |
|
+5.58% | +12.94% |
21/06 | Morgan Stanley Adjusts Price Target on Centessa Pharmaceuticals to $11 From $8, Maintains Equalweight Rating | MT |
10/06 | Centessa Pharmaceuticals Appoints John Crowley as CFO | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+12.94% | 1.02B | |
+23.13% | 46.93B | |
+36.90% | 39.08B | |
-8.73% | 38.48B | |
+28.09% | 31.01B | |
-12.26% | 26.14B | |
+10.57% | 25.88B | |
+45.05% | 14.15B | |
+32.23% | 12.53B | |
-6.56% | 11.36B |
- Stock Market
- Equities
- CNTA Stock
- News Centessa Pharmaceuticals plc
- Centessa Pharmaceuticals' Q4 Net Loss Narrows